Aardvark Therapeutics' HERO Clinical Trial Informational Webinar - October 15, 2025
Автор: Prader-Willi Syndrome Association
Загружено: 2025-10-22
Просмотров: 65
Описание: Watch this webinar to learn more about Aardvark Therapeutics HERO clinical trial of ARD-101, jointly hosted by PWSA | USA and FPWR. This trial is a global Phase 3 clinical trial investigating ARD-101, an innovative, orally administered treatment designed to help reduce hyperphagia (excessive hunger) and food-seeking behaviors in individuals with Prader-Willi syndrome. This randomized, double-blind, placebo-controlled trial is an important step toward identifying a potential new treatment option for the PWS community, and now, trial sites across the United States are actively enrolling participants. https://www.heroforpws.com/ | https://www.heroforpws.com/es
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке: